Surgical management of secondary hyperparathyroidism in uremia

American Journal of the Medical Sciences

Volumn 317, Issue 6, 1999, Pages 390-397

  Tominaga, Yoshihiro ^a  

^a NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

Author keywords

Parathyroid hyperplasia; Parathyroidectomy; Recurrent hyperparathyroidism; Secondary hyperparathyroidism; Uremia

Indexed keywords

AUTOGRAFT; CONFERENCE PAPER; HEMODIALYSIS; HISTOPATHOLOGY; HORMONE RESPONSE; HUMAN; PARATHYROID FUNCTION; PARATHYROID HYPERPLASIA; PARATHYROIDECTOMY; RECEPTOR DENSITY; RECURRENT DISEASE; SECONDARY HYPERPARATHYROIDISM; UREMIA;

EID: 0033505932     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9629(15)40552-X     Document Type: Conference Paper

References (50)

1. Akizawa T, Fukagawa M, Koshikawa S, et al. Recent progress in management of secondary hyperparathyroidism of chronic renal failure. Curr Opin Nephrol Hypertens 1989; 2:558-65.
2. Fournier A, Moriniere PH, Oprisiu R, et al. 1-alpha-Hydroxyvitamin D3 derivatives in the treatment of renal bone diseases: justification and optimal modalities of administration. Nephron 1995;71:254-83.
3. Llach F. Secondary hyperparathyroidism in renal failure: the trade-off hypothesis revisited. Am J Kidney Dis 1995;25: 663-79.
4. Slatopolsky E, Weerts C, Thielan J, et al. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecalciferol in uremic patients. J Clin Invest 1984;74:2136-43.
5. 3 pulse therapy in hemodialysis patients with severe secondary hyperparathyroidism. Nephron 1991; 57:23-8.
6. Delmez JA, Tindire C, Grooms P, et al. Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. A role for increased sensitivity to calcium. J Clin Invest 1989;83:1349-55.
7. Andress DL, Norris KC, Coburn JW, et al. Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure. N Engl J Med 1989;321:274-9.
8. Fukagawa M, Okazaki R, Takano K, et al. Regulation of parathyroid hyperplasia by calcitriol-pulse therapy in patients on long-term dialysis. N Engl J Med 1990;323:421-2.
9. Llach F. Parathyroidectomy in chronic renal failure: indications, surgical approach and use of calcitriol. Kidney Int 1990;38:S62-8.
10. Rothmund M. Surgical treatment of secondary hyperparathyroidism: indication, operative management and result. Prog Surg 1986;18:186-205.
11. Tominaga, Y, Numano M, Uchida K, et al. Parathyroidectomy for patients with renal hyperparathyroidism refractory to calcitriol pulse therapy. J Bone Miner Metab 1994; 12(Suppl. 1):S99-104.
12. Malmaeus J, Grimelius L, Johansson H, et al. Parathyroid pathology in hyperparathyroidism secondary to chronic renal failure. Scand J Urol Nephrol 1984;18:157-66.
13. Grimelius L, Akerstrom G, Johansson H, et al. Parathyroid gland: functional endocrine pathology. 1st ed. pp 375, Blackwell Scientific Publications, Cambridge (UK); 1991.
14. Tominaga Y, Sato K, Tanaka Y, et al. Histopathology and pathophysiology of secondary hyperparathyroidism due to chronic renal failure. Clin Nephrol 1995;144:S42-7.
15. Tominaga Y, Tanaka Y, Sato K, et al. Histopathology, pathophysiology and indications for surgical treatment of renal hyperparathyroidism. Semin Surg Oncol 1997;13:78-86.
16. Tominaga Y, Tanaka Y, Sato K, et al. Recurrent renal hyperparathyroidism and DNA analysis of autografted parathyroid tissue. World J Surg 1992;16:595-602.
17. Ohta K, Manabe T, Katagiri M, et al. Expression of proliferating cell nuclear antigens in parathyroid glands of renal hyperparathyroidism. World J Surg 1994;18:625-9.
18. Loda M, Lipman J, Cukor B, et al. Nodular foci in parathyroid adenomas and hyperplasia: An immunohistochemical analysis of proliferative activity. Hum Pathol 1994;25:1050-6.
19. Oka T, Yoshida T, Shresth GR, et al. Immunohistochemical study of nodular hyperplastic parathyroid glands in patients with secondary hyperparathyroidism. Virchows Arch A Pathol Anat Histopathol 1988;413:53-60.
20. Tominaga Y, Kohara S, Namii Y, et al. Clonal analysis of nodular parathyroid hyperplasia in renal hyperparathyroidism. World J Surg 1996;20:744-50.
21. Tominaga Y. Mechanism of parathyroid tumourigenesis in uraemia. Nephrol Dial Transplant 1999;14(Suppl 1):63-5.
22. Tominaga Y, Takagi H. Molecular genetics of hyperparathyroid disease. Curr Opin Nephrol Hypertens 1996;5:336-41.
23. Falchetti A, Bale AE, Amorosi A, et al. Progression of uremic hyperparathyroidism involves allelic loss on chromosome 11. J Clin Endocrinol Metab 1993;76:139-44.
24. Arnold A, Brown MF, et al. Monoclonality of parathyroid tumors in chronic renal failure and primary parathyroid hyperplasia. J Clin Invest 1995;95:2047-53.
25. Farnebo F, Teh BT, Dotzenrath C, et al. Differential loss of heterozygosity in familial, sporadic, and uremic hyperparathyroidism. Hum Genet 1997;99:342-9.
26. Brown EM, Wilson RE, Eastman R. Abnormal regulation of parathyroid hormone release by calcium in secondary hyperparathyroidism. J Clin Endocrinol Metab 1982;54:172-9.
27. Wallfelt CH, Larsson R, Gylfe E, et al. Secretary disturbance in hyperplastic parathyroid nodules of uremic hyperparathyroidism: implication for parathyroid autotransplantation. World J Surg 1988;12:431-8.
28. 2+-sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin Endocrinol Metab 1996;81:1598-606.
29. Gogusev J, Duchambon P, Hory B, et al. Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism. Kidney Int 1997;51:328-36.
30. 3 in the parathyroid glands of patients with renal failure. N Engl J Med 1987;316:1573-7.
31. 3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 1993;92:1436-43.
32. Giangrade A, Castiglioni A, Solbiati L, et al. Ultrasound-guided percutaneous fine-needle ethanol injection into parathyroid glands in secondary hyperparathyroidism. Nephrol Dial Transplant 1992;7:412-21.
33. Tominaga Y, Sato K, Numano M, et al. Indications for parathyroidectomy in renal hyperparathyroidism. Acta Chir Austriaca Suppl 1996;124:10-3.
34. Tominaga Y, Tanaka Y, Sato K, et al. Surgical treatment of secondary hyperparathyroidism. J Bone Miner Metab 1991;3:294-300.
35. Tominaga Y, Numano M, Tanaka Y, et al. Surgical treatment of renal hyperparathyroidism. Semin Surg Oncol 1997; 13:87-96.
36. Tominaga Y, Uchida K, Sato K, et al. Parathyroidectomy before and after renal transplantation. Transplant Proc 1992; 124:1861-2.
37. Uchida K, Tominaga Y, Tanaka Y, et al. Renal transplantation and secondary hyperparathyroidism. Semin Surg Oncol 1997;13:97-103.
38. Takagi H, Tominaga Y, Uchida K, et al. Subtotal versus total parathyroidectomy with forearm autograft for secondary hyperparathyroidism in chronic renal failure. Ann Surg 1984;200:18-23.
39. Takagi H, Tominaga Y, Uchida K, et al. Image diagnosis of parathyroid glands in chronic renal failure. Ann Surg 11983;98:74-9.
40. Akerstrom G, Malmaeus J, Bergstrom R. Surgical anatomy of human parathyroid glands. Surgery 1984;95:14-21.
41. Tominaga Y, Tanaka Y, Sato K, et al. Supernumerary parathyroid glands in surgery for renal hyperparathyroidism. Acta Chir Austriaca Suppl 1996;124:16-9.
42. Numano M, Tominaga Y, Uchida K, et al. Surgical significance of supernumerary parathyroid glands in renal hyperparathyroidism. World J Surg 1998;22:1098-102.
43. Tominaga Y, Sato K, Numano M, et al. Surgical treatment of renal hyperparathyroidism. Asian J Surg 1994;17:121-6.
44. Takagi H, Tominaga Y, Tanak Y, et al. Total parathyroidectomy with forearm autograft for secondary hyperparathyroidism in chronic renal failure. Ann Sur 1988;206:639-44.
45. Katagiri M, Fukunaga M, Tomomitsu T, et al. Measurement of radial and vertebra bone mineral density in patients with hyperparathyroidism using dual energy X-ray absorptiometry. Endocr Surg 1990;7:439.
46. Qi Q, Monier-Faugere MC, Geng Z, et al. Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis. Am J Kidney Dise 1995;26:622-31.
47. Hergan K, Neyer U, Doringer W. MR imaging in graft-dependent recurrent hyperparathyroidism after parathyroidectomy and autotransplantation. J Magn Reson Imaging 1995;5:541-4.
48. Francisco ALM, Amado JA, Casanova D, et al. Recurrence of hyperparathyroidism after total parathyroidectomy with autotransplantation: A new technique to localize the source of hormone excess. Neprone 1991;58: 306-9.
49. Tominaga Y, Numano M, Uchida K, et al. Lung metastasis from parathyroid carcinoma causing recurrent renal hyperparathyroidism in hemodialysis patients: report of a case. Surg Today 1995;25:984-6.
50. Cryns VL, Thor A, Xu HJ, et al. Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma. N Engl J Med 1994;330:757-61.